SPARQL
Query
Update
Search
Quick
Advanced
Co-occurrence
RelFinder
About
Sources
Admin
System Info
Repository Management
Search Configuration
Sources
20696631
Source:
http://linkedlifedata.com/resource/pubmed/id/20696631
Search
Subject
(
62
)
Predicate
Object
All
Download in:
JSON
RDF
N3/Turtle
N-Triples
Switch to
Custom View
Named Graph
All
UniProt
NCBIGene
DrugBank
ClinicalTrials
UMLS
PubMed
Mappings
MentionedEntities
Language
All
English
Español
Português
Français
Deutsch
Русский
日本語
Български
Inference
Explicit and implicit
Explicit only
Implicit only
Statements in which the resource exists as a subject.
Predicate
Object
rdf:type
pubmed:Citation
lifeskim:mentions
umls-concept:C0019704
,
umls-concept:C0021311
,
umls-concept:C0030705
,
umls-concept:C0032893
,
umls-concept:C0205210
,
umls-concept:C0205547
,
umls-concept:C0596545
,
umls-concept:C1667052
pubmed:issue
6
pubmed:dateCreated
2010-8-10
pubmed:abstractText
Few data are available about the efficacy of maraviroc (MVC) during routine use. We characterized indications for MVC use and the efficacy of MVC in clinical practice.
pubmed:language
eng
pubmed:journal
http://linkedlifedata.com/resource/pubmed/journal/9517857
pubmed:citationSubset
IM
pubmed:chemical
http://linkedlifedata.com/resource/pubmed/chemical/Antiviral Agents
,
http://linkedlifedata.com/resource/pubmed/chemical/Cyclohexanes
,
http://linkedlifedata.com/resource/pubmed/chemical/Receptors, CCR5
,
http://linkedlifedata.com/resource/pubmed/chemical/Triazoles
,
http://linkedlifedata.com/resource/pubmed/chemical/maraviroc
pubmed:status
MEDLINE
pubmed:month
Jun
pubmed:issn
0949-2321
pubmed:author
pubmed-author:BalduinMM
,
pubmed-author:BrakelRR
,
pubmed-author:HäussingerDD
,
pubmed-author:JensenBB
,
pubmed-author:KaiserRR
,
pubmed-author:OetteMM
,
pubmed-author:ReuterSS
,
pubmed-author:Sierra-AragonSS
pubmed:issnType
Print
pubmed:day
28
pubmed:volume
15
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
231-7
pubmed:meshHeading
pubmed-meshheading:20696631-Antiviral Agents
,
pubmed-meshheading:20696631-Cyclohexanes
,
pubmed-meshheading:20696631-Drug Resistance, Viral
,
pubmed-meshheading:20696631-Drug Therapy, Combination
,
pubmed-meshheading:20696631-Female
,
pubmed-meshheading:20696631-Gene Expression Regulation, Viral
,
pubmed-meshheading:20696631-Genotype
,
pubmed-meshheading:20696631-HIV Infections
,
pubmed-meshheading:20696631-HIV-1
,
pubmed-meshheading:20696631-Humans
,
pubmed-meshheading:20696631-Male
,
pubmed-meshheading:20696631-Middle Aged
,
pubmed-meshheading:20696631-Prospective Studies
,
pubmed-meshheading:20696631-Receptors, CCR5
,
pubmed-meshheading:20696631-Salvage Therapy
,
pubmed-meshheading:20696631-Treatment Outcome
,
pubmed-meshheading:20696631-Triazoles
,
pubmed-meshheading:20696631-Viral Tropism
,
pubmed-meshheading:20696631-Virus Internalization
,
pubmed-meshheading:20696631-Virus Replication
pubmed:year
2010
pubmed:articleTitle
Maraviroc in treatment-experienced patients with HIV-1 infection - experience from routine clinical practice.
pubmed:affiliation
Clinic for Gastroenterology, Hepatology and Infectious, University Hospital, Düsseldorf, Germany. Stefan.reuter@med.uni-duesseldorf.de
pubmed:publicationType
Journal Article
,
Clinical Trial